1. American College of Chest Physicians (1992) American college of chest physicians/society of critical care medicine consensus conference. Critical Care Medicine 20: 864–874.
Google Scholar | Crossref | Medline | ISI2. Singer, M, Deutschman, CS, Seymour, CW, et al. (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8): 801–810.
Google Scholar | Crossref | Medline | ISI3. Fleischmann, C, Scherag, A, Adhikari, NKJ, et al. (2016) Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. American Journal of Respiratory and Critical Care Medicine 193(3): 259–272.
Google Scholar | Crossref | Medline | ISI4. Charchaflieh, J, Rushbrook, J, Worah, S et al. (2015) Activated complement factors as disease markers for sepsis. Disease Markers 2015: 382463.
Google Scholar | Crossref | Medline5. Gawaz, M, Vogel, S, Pfannenberg, C, et al. (2014) Implications of glycoprotein VI for theranostics. Thrombosis and Haemostasis 112(07): 26–31.
Google Scholar | Crossref | Medline6. Elias, ACGP, Matsuo, T, Grion, CMC, et al. (2012) Incidence and risk factors for sepsis in surgical patients: a cohort study. Journal of Critical Care 27(2): 159–166.
Google Scholar | Crossref | Medline7. Zeng, M, Chang, M, Zheng, H, et al (2016) Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis. The American Journal of Emergency Medicine 34(3): 375–380.
Google Scholar | Crossref | Medline8. Shankar-Hari, M, Ambler, M, Mahalingasivam, V, et al. (2016) Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies. Critical care (London, England) 20(1): 101–103.
Google Scholar | Crossref | Medline9. Guo, H, Zhou, L-X, Ma, H, et al. (2017) Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia. Oncology Letters 14(1): 383–389.
Google Scholar | Crossref | Medline10. Erdfelder, E, Faul, F, Buchner, A (1996) GPOWER: a general power analysis program. Behavior Research Methods, Instruments, & Computers 28(1): 1–11.
Google Scholar | Crossref11. Bocskei, RM, Meszaros, M, Tarnoki, AD, et al. (2020) Circulating soluble urokinase-type plasminogen activator receptor in obstructive sleep apnoea. Medicina 56(2): 77.
Google Scholar | Crossref12. Mohamed, AKS, Mehta, AA, James, P (2017) Predictors of mortality of severe sepsis among adult patients in the medical intensive care unit. Lung India: Official Organ of Indian Chest Society 34(4): 330–335.
Google Scholar | Crossref | Medline13. Kim, CH, Kim, SJ, Lee, MJ, et al. (2015) An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock. PloS one 10(3): e0119437.
Google Scholar | Medline | ISI14. Ghany, MG, Kim, H-Y, Stoddard, A, et al. (2011) Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial. Hepatology 54(5): 1527–1537.
Google Scholar | Crossref | Medline15. Li, W, Wang, M, Zhu, B, et al. (2020) Prediction of median survival time in sepsis patients by the SOFA score combined with different predictors. Burns & Trauma 8: tkz006.
Google Scholar | Crossref | Medline16. Koch, A, Voigt, S, Kruschinski, C, et al. (2011) Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Critical care (London, England) 15(1): R63–R64.
Google Scholar | Crossref | Medline17. Loonen, AJM, de Jager, CPC, Tosserams, J, et al. (2014) Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PloS one 9(1): e87315.
Google Scholar | Crossref | Medline18. López-Izquierdo, R, Brio-Ibañez, Pd, Martín-Rodríguez, F, et al. (2020) Role of qSOFA and SOFA scoring systems for predicting in-hospital risk of deterioration in the emergency department. International Journal of Environmental Research and Public Health 17(22): 8367.
Google Scholar | Crossref19. Jalkanen, V, Yang, R, Yang, R, et al. (2013) SuPAR and PAI-1 in critically ill, mechanically ventilated patients. Intensive Care Medicine 39(3): 489–496.
Google Scholar | Crossref | Medline20. Silvestre, J, Coelho, L, Pereira, JG, et al. (2018) suPAR in the assessment of post intensive care unit prognosis: a pilot study. Revista Brasileira de terapia intensiva 30(4): 453–459.
Google Scholar | Crossref | Medline21. Perés Wingeyer, SD, Cunto, ER, Nogueras, CM, et al. (2012) Biomarkers in sepsis at time zero: intensive care unit scores, plasma measurements and polymorphisms in Argentina. Journal of infection in developing countries 6(07): 555–562.
Google Scholar | Crossref | Medline22. Vincent, JL, Sakr, Y, Reinhart, K, et al. (2005) Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Critical Care (London, England) 9: R745–R754.
Google Scholar | Crossref | Medline23. Prabhakaran, P, Ware, LB, White, KE, et al. (2003) Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 285(1): L20–L28.
Google Scholar | Crossref | Medline24. Sapru, A, Curley, MAQ, Brady, S, et al. (2010) Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. Intensive care medicine 36(1): 157–163.
Google Scholar | Crossref | Medline